Human Pharmaceutical Portfolio

Jakavi 20 mg Tablet

Product information from the Times Medicament supplied portfolio. Contact our export team to confirm current sourcing options, market requirements and commercial availability.

Molecule / StrengthRuxolitinib 20 mg
ManufacturerNovartis Healthcare Pvt Ltd
CategoryBone Marrow Disorder
This product is listed in the supplied Times Medicament unregistered product portfolio. Listing does not by itself confirm registration, licensing or availability in any specific country. Market-specific confirmation is required.